The design of peptidomimetic small molecules, such as amino acid substituted xanthones, has become an attractive research field. The strategy of linking molecules with xanthone scaffold to peptide moieties demonstrated to be successful for the development of new antimicrobial agents. Our group has already described xanthones as promising antimicrobials, and as inhibitors of antimicrobial resistance mechanisms. Enantioselectivity studies associated with biological activities were also performed by us, and for some chiral derivatives of xanthones (CDXs) differences were found for the respective enantiomers. Herein, a small library of CDXs was synthesized and their enantiomeric purity was evaluated by chiral liquid chromatography. Enantiomeric ratio values higher than 99% were achieved. The potential of CDXs as antimicrobial agents, and their application to improve the activity of common antibiotics or to reverse bacterial mechanism of resistance were studied. In addition, to gain a better insight on how the active compounds bind to the bacterial efflux pumps, in silico studies were performed. Hit compounds were suggested and, in some cases, enantioselectivity was evident.